Antisense antibacterial method and compound
AssigneeAVI BioPharma, Inc.
InventorsBruce L. Geller, Jesse D. Deere, Patrick L. Iversen, Dwight D. Weller
Life of this patent
Estimating the term…
Loading patent…
AssigneeAVI BioPharma, Inc.
InventorsBruce L. Geller, Jesse D. Deere, Patrick L. Iversen, Dwight D. Weller
Estimating the term…
A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50° to 60° C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.
A method of inhibiting the growth of Escherichia coli, Salmonella typhimurium, or Yersinia pestis pathogenic bacterial cells, comprising exposing the bacterial cells to a growth-inhibiting amount of an antisense oligonucleotide compound, composed of morpholino subunits and phosphorus-containing intersubunit linkages joining a morpholino nitrogen of one subunit to a 5′ exocyclic carbon of an adjacent subunit, and having:
Dependencies are inferred from the claim text.